Results: Analyses of between-group differences replicated previous findings, indicating that PTSD-diagnosed individuals self-reported poorer sleep quality, objectively demonstrated less sleep depth, and evidenced declarative memory deficits in comparison to HC. Integrative SVM-learning distinguished HC from trauma participants with 80% accuracy using a combination of five features, including subjective and objective sleep, neutral declarative memory, and metabolite variables. PTSD and TE participants could be distinguished with 70% accuracy using a combination of subjective and objective sleep variables but not by metabolite or declarative memory variables.
| BACKGROUND
Sleep disturbances and memory deficits are prominent features of posttraumatic stress disorder (PTSD) and are also strongly implicated in PTSD susceptibility and symptom development (Brewin, Kleiner, Vasterling, & Field, 2007; Germain, 2013) . Although these disturbances and deficits are sometimes considered secondary symptoms of the disorder, disturbing dreams, insomnia, and poor memory are reported by most diagnosed individuals (Agorastos, Kellner, Baker, & Otte, 2014; Pace-Schott, Germain, & Milad, 2015) . Furthermore, recent evidence suggests that these sleep and memory-related alterations may be meaningfully associated, because of the role that sleep plays in memory consolidation (Feld & Diekelmann, 2015; Goerke, Muller, & Cohrs, 2017; Lipinska, Timol, Kaminer, & Thomas, 2014) . A better understanding of the role of trauma-induced sleep and memory disturbances in PTSD development may help drive improved diagnostic and treatment approaches.
Data derived from structured clinical interviews and self-report symptom checklists and questionnaires suggest that PTSD-diagnosed individuals consistently experience numerous forms of sleep disruption. These include difficulties in falling asleep, frequent awakenings from sleep, shorter sleep duration, restless sleep, daytime fatigue, and nightmares (Buysse et al., 2008; Giosan et al., 2015; Werner, Griffin, & Galovski, 2016) .
However, investigations using polysomnography (PSG) have produced inconsistent results regarding the nature and magnitude of sleep disturbances in PTSD. Some studies have found decreased rapid eye movement (REM) duration during sleep (Hefez, Metz, & Lavie, 1987; Lavie, Hefez, Halperin, & Enoch, 1979; Lipinska et al., 2014; Mikulincer, Glaubman, Wasserman, Porat, & Birger, 1989) , whereas others have found either normal or prolonged REM durations (Dow, Kelsoe, & Gillin, 1996; Engdahl, Eberly, Hurwitz, Mahowald, & Blake, 2000; Glaubman, Miculincer, Porat, Wasserman, & Birger, 1990; Mellman, Kulick-Bell, Ashlock, & Nolan, 1995) . Similarly, abnormalities in slow-wave sleep (SWS) are found inconsistently, with some studies reporting decreased SWS in PTSD-diagnosed individuals relative to controls (Fuller, Waters, & Scott, 1994; Glaubman et al., 1990; Habukawa, Uchimura, Maeda, Kotorii, & Maeda, 2007; Mikulincer et al., 1989; Yetkin, Aydin, & Ozgen, 2010) , whereas others report no between-group differences (Dow et al., 1996; Hurwitz, Mahowald, Kuskowski, & Engdahl, 1998; Ross et al., 1994; Woodward, Murburg, & Bliwise, 2000) . Meta-analyses attribute these inconsistencies to between-study differences in methodology, as well as variability in controlling for moderating variables such as age, gender, trauma type, and psychiatric comorbidities that may influence the nature and extent of sleep disruption (Kobayashi, Boarts, & Delahanty, 2007) .
Inconsistences may also be related to the lack of comprehensive symptom descriptions. For instance, the frequency and magnitude of hyperarousal symptoms are rarely described, even though these have been linked with disturbed sleep Mellman, Kumar, Kulick-Bell, Kumar, & Nolan, 1995;  van Liempt et al., 2013) . In these studies, hyperarousal symptoms have been indexed using self-report measures, psychophysiological measures (heart rate variability), and a number of biomarkers (levels of cortisol, adrenocorticotropic hormone, and noradrenaline derived from plasma or urine metabolites). Measures of noradrenergic functioning are particularly useful in characterising the relationship between sleep disturbance and hyperarousal in PTSD, because noradrenaline is activated during sympathetic activation of the autonomic nervous system under conditions of perceived or actual threat. Furthermore, Mellman, Kumar, et al. (1995) found that PTSD-diagnosed participants, in comparison with healthy controls, had elevated nighttime noradrenergic activity and that the extent of this activation was correlated with the degree of sleep disturbance. However, the lack of consistent objective sleep findings indicates a need for improved biomarker approaches that might help differentiate reliably between those with and without a diagnosis of PTSD.
A large body of research applying memory measures (including list-learning, narrative recall tasks, and paired associated learning) to the study of PTSD has demonstrated prominent memory deficits, associated with small-to-moderate effect sizes, in affected individuals (Brewin et al., 2007; Johnsen & Asbjornsen, 2008) . Such deficits are strongly related to reduced hippocampal volume in PTSD-diagnosed individuals (Bremner et al., 1995; Vythilingam et al., 2005) . Recent research investigating the importance of healthy sleep (specifically, intact sequences of, and transitions between, early-night SWS and late-night REM sleep) for the processing and consolidation of memories encoded during waking has indicated that in PTSD, disturbed sleep and poor performance on recall and recognition tasks may be closely related. Independent studies have demonstrated that either disrupted REM sleep (Lipinska et al., 2014) The present study assessed the utility of combining 74 different features including subjectively and objectively measured sleep disturbance, declarative memory deficits, and changes in biological markers of hyperarousal (noradrenergic and adrenergic metabolites) across those diagnosed with PTSD, those exposed to trauma and healthy controls. Our objective was to identify the minimum combination of features with the highest diagnostic accuracy to characterise PTSD.
We conducted this exploration using supervised multivariate classification methods to integrate and identify a combination of features that may be capable of accurate PTSD classification.
| METHODS
This study, which was part of a larger study investigating relations between cognition, affect, and sleep in PTSD-diagnosed individuals (Lipinska & Thomas, 2017) , had a cross-sectional quasi-experimental design.
| Participants
Sixty women were enrolled into the study and assigned to three groups (N = 20 each): PTSD, trauma survivors without PTSD (TE), and healthy controls (HC). We opted to recruit participants in such a way as to be able to detect any significant results based on medium effect sizes, using a conservative estimate of f = 0.33 from a previous study using a similar cohort (effect sizes range: f = 0.33 to f = 0.73; Lipinska et al., 2014) . A power analysis revealed that to achieve power of 0.8 with α set at 0.05, we needed to recruit at least 60 participants.
All participants in the PTSD and TE groups were adults who had experienced a single sexual assault, which was considered the index trauma. Participants were recruited through a local nonprofit organisation that provides a counselling service to sexual assault survivors and through advertisements placed in local newspapers. The three groups were aggregate-matched on age (for the entire sample, 25.3 ± 4.1 years), general intellectual functioning (for the entire sample, Wechsler IQ = 82.3 ± 14.2), level of income (for the entire sample, 4,706.0 ± 2,828.0 ZAR), and smoking habits (13% of all participants smoked cigarettes regularly). The sample included seven participants with asymptomatic HIV. The PTSD and TE groups were aggregate matched on time since trauma (overall, 1.3 ± 1.0 years; Table 1 ). All participants had no history of childhood sexual trauma and of alcohol or illicit substance abuse and were free of psychoactive medication.
Full ethical approval was obtained from the relevant bodies at the hosting institution, and all participants provided written informed consent.
A trained researcher used the Clinician-Administered PTSD Scale (CAPS; Blake et al., 1995) to measure the presence and severity of PTSD symptoms. We used a moderate scoring rule, which stipulated that a CAPS score of at least 45 must be reached for a diagnosis of PTSD to be made and that there must be the appropriate Diagnostic and Statistical Manual, Fourth Edition, Text Revision distribution of symptoms across clusters. PTSD diagnosis was confirmed using the Mini International Neuropsychiatric Inventory (Sheehan et al., 1998) .
Participants had to meet both CAPS and Mini International Neuropsychiatric Inventory PTSD diagnosis criteria to remain eligible for inclusion in the PTSD group. The presence and severity of depression was rated using the Beck Depression Inventory (Beck, Steer, & Brown, 1996) . To provide an estimate of general intellectual functioning, participants completed the performance subtests of the Wechsler Abbreviated Scale of Intelligence (D. Wechsler, 1999) . Potential participants were excluded from the PTSD and TE groups if they had a current primary psychiatric diagnosis that was not secondary to trauma and were excluded from the HC group if they displayed any psychiatric diagnosis. Eligible participants were scheduled for two night sessions and one day session and were required to refrain from vigorous exercise, alcohol, nicotine, and caffeinated drinks for 12 hr prior to testing.
| Sleep-wake assessment and memory performance
A blocked randomisation approach assigned an equal number of participants from each group to either two consecutive night sessions followed by a day session or a day session followed by two consecutive night sessions. The day and the night sessions were separated by at least 48 hr and occurred within a week of each other. (Sheslow & Adams, 2003) . Administration of these tests followed standardised procedures. That is to say, an immediate recall trial followed initial presentation of each stimulus set (LM and SM: a oneparagraph story in each case; WL: a list of 12 semantically unrelated words), and an uncued delayed recall trial followed some time after that. The only exception to the standard administration procedures was that the delayed recall trial followed a period of sleep, rather than the usual 25-35 min of filled activity. After completing that set of cognitive tests, participants prepared for bedtime and were attached to a 16-channel Nihon Kohden NeuroFax EEG9000 electroencephalograph adapted for sleep research.
Upon waking after an 8-hr sleep opportunity, an adapted version of the PSQI (Laboratory PSQI; Supplementary Appendix A) assessed subjective laboratory sleep during the night, and delayed free and cued recall trials of the three memory tasks (LM, WL, and SM) were administered. Both the PSQI and Laboratory PSQI were scored, following convention, to calculate a Global Score capturing overall sleep quality over the reporting period (Buysse et al., 1989) .
For the day session, participants arrived at the laboratory at approximately 08h00 and completed parallel versions of the LM, WL, and SM immediate recall tasks. After 8 hr of waking activity, they returned to the lab so that delayed free tasks could be administered.
Participants were instructed to carry out their ordinary daily activities during the 8-hr wake period but not to nap. To estimate declarative memory performance, immediate recall, delayed recall, and retention (i.e., comparison of immediate with delayed recall and expressed as a percentage) scores were derived from each of the LM, WL, and SM tasks. Three composite scores were also calculated averaging immediate recall, delayed recall, and retention Z-scores across tasks. Retention was the primary variable of interest.
| PSG acquisition, analysis, and data preprocessing
To ensure reliable PSG recording, we applied a combination referential and bipolar montage with the bipolar derivations being F3-C3, C3-P3, P3-O1, and F4-C4, C4-P4, P4-O2, and the referential derivations being F3-A2, C3-A2, O3-A2, and F4-A1, C4-A1, O4-A1. Eye movements, muscle tonus, and heart rate were recorded on two electrooculography channels, and on one electromyography and one electrocardiography channel, respectively. Standardised filters for recording sleep were employed for the electroencephalograph and electrooculography (0.5-35 Hz), electromyography (10-70 Hz), and electrocardiography (1-70 Hz) leads to ensure integrity of the signal.
The ground electrode was placed on the middle of the forehead.
PSG records were analysed according to Rechtschaffen and Kales (1968) 
| Measurement of noradrenergic and adrenergic metabolites
Participants were asked to micturate into containers holding 10-ml 6 M HCl preservative during three periods: (1) 08h00-16h00, (2) 16h00-24h00, and (3) 24h00-08h00. The first two collection periods occurred within the day session, whereas the third occurred during the N2 session. During each collection period, participants voided into a receptacle and transferred their urine to a convenient and appropriately marked small cooler box or kept directly at 4°C. Eventually, each bottle was transferred to the local National Health Laboratory Service where volumes for the three collections were measured and aliquots obtained.
The samples were then frozen at −80°for assay. The samples were then analysed using gas chromatography and mass spectrometry. An Agilent Technology 7890A gas chromatographer and 5975C mass spectrometer were used for analysis. Samples were analysed according to standard gas chromatography-mass spectrometry procedures described elsewhere (Burtis, Ashwood, & Bruns, 2012; Naccarato, Gionfriddo, Sindona, & Tagarelli, 2014) . Such analysis of urinary-derived normetadrenaline and metadrenaline metabolites is considered a robust, valid, and reliable method to estimate noradrenergic and adrenergic activity respectively. Furthermore, this analytic procedure provides adequate protection against interference from drugs, drug metabolites, exercise, and stress (Peaston & Weinkove, 2004) .
| Statistical analyses
Prior to SVM analysis, we conducted a number of conventional analyses to examine between-group differences with respect to sleep, memory, and metabolite measures. Data related to these variables
were assessed for normality with the Shapiro-Wilk test, and then either a one-way analysis of variance or a Kruskal-Wallis analysis of variance with Tukey honestly significant difference post hoc correction was implemented, respectively. Tukey's method was used to create confidence intervals for all pairwise differences between-group level means while controlling for 95% family error rate. Models were adjusted for age, nicotine, and HIV status to control for potential confounding effects on PSG. Correlations among clinical assessment measures (CAPS and PSQI) across PTSD and TE groups were estimated using Spearman coefficient. Significant correlations were inspected for outlying data points, which were removed accordingly. these four machine-learning methods have been reviewed elsewhere (Simon et al., 2007) . A detailed schematic of the current approach is summarised in Figure SS1 in the Supporting Information.
3 | RESULTS 
| Clinical characteristics of PTSD and TE participants

| PSG and declarative memory analysis
Between-group analyses on PSG data from N2 showed that compared with HC participants, PTSD and TE participants displayed prolonged NREM 1% (p = 0.04 and p = 0.03, respectively), and decreased SWS% (p = 0.01 and p = 0.02, respectively; see Table SS1 in the Supporting Information).
Declarative memory performance was measured during the day and N2 sessions (Table S2 ). Regarding data from the night sessions, PTSD participants performed significantly more poorly than HC on 
| Noradrenergic and adrenergic metabolite analysis
No significant differences were observed in metabolite levels either between groups or at any of the specified collection times (Table S3) .
Additionally, no metabolite measurement was significantly associated with PSQI Global Score or with the CAPS Total Score.
| Exploring PTSD classification with machine-learning
Using SVM-learning two separate models were specified to distinguish between (a) HC versus trauma groups (PTSD and TE) and (b) PTSD versus TE. We identified five features able to discriminate HC from PTSD and TE participants with 80% accuracy (Figure 1a -c and Table   S4a and S4b). The composition of this classifier was populated with one memory feature (WL delayed recall, night session), three sleep features (PSQI, SWS% N2, awakenings N2), and one biological marker (metanephrine 16h00-24h00; Figure 1b and Table 4a ). The second model identified five features able to discriminate PTSD from TE participants with 70% accuracy using SVM classification (Figure 1d -f and Table S4b ). The composition of this classifier was populated with five sleep features (PSQI, subjective sleep N2, normal bedtime, arousals N2, and awakenings N2; Figure 1e ).
| DISCUSSION
We set out to investigate relationships between sleep, memory, and noradrenergic and adrenergic metabolites in PTSD using conventional parametric/nonparametric analyses and exploratory supervised (Davis & Wright, 2007; Germain et al., 2012; Raskind et al., 2013; Talbot et al., 2014) . Together, these strands of the literature suggest that sleep disruption is not an isolated symptom of PTSD, and that it may, in fact, be mechanistically associated with other cognitive, emotional, and endocrine functions within the disorder. poorer subjective home sleep, and earlier bedtime were associated with a PTSD diagnosis rather than with trauma exposure alone.
| Features differentiating PTSD, TE, and HC participants
Although these classifiers contrast with respect to subjective sleep quality between the laboratory and home environment, previous studies have found that PTSD-diagnosed individuals self-report better sleep quality in the laboratory than in the home environment (Hurwitz et al., 1998; Kobayashi, Huntley, Lavela, & Mellman, 2012; Lipinska & Thomas, 2017; Spoormaker & Montgomery, 2008 Several recent studies have demonstrated that fragmentation of sleep is an important characteristic of sleep disruption in PTSD (Mellman et al., 2002; Mellman, Kobayashi, Lavela, Wilson, & Hall Brown, 2014; van Liempt et al., 2011) .
Classifiers that differentiated between those with trauma exposure (PTSD and TE participants) and those without (HC participants)
indicated that exposure was associated with poorer subjective and objective sleep quality (that is, a higher PSQI score and less SWS percentage), elevated evening adrenaline, and poorer neutral declarative memory at postsleep awakening (Figure 1a-c) . These findings are important because previous research has shown that activation of the sympathetic branch of the autonomic nervous system in the evening-proposed in this study by descriptively elevated adrenaline in trauma-exposed individuals-is associated with poor sleep quality, including disrupted early-night SWS (Mitchell & Weinshenker, 2010 ).
Because SWS is critical for memory consolidation (Feld & Diekelmann, 2015; Marshall, Helgadottir, Molle, & Born, 2006; Walker, 2009) , the implication here is that lowered SWS percentage in trauma-exposed individuals may contribute to poor neutral declarative memory, a conjecture consistent with data reported in one other study (van Liempt et al., 2011) .
This conjecture is supported, in part, by the observation that poorer neutral declarative memory performance was associated with trauma exposure only at post-sleep awakening, rather than before sleep or across waking according to the SVM model. This interpretation is tempered somewhat because the reported measure of neutral declarative memory did not control for presleep learning. Betweengroup comparisons of several measures of neutral declarative memory performance also demonstrated postsleep patterns of deficits in trauma-exposed individuals. Collectively, these findings permit the cautious speculation that sleep-dependent memory consolidation is impaired in individuals with trauma exposure. We are currently analysing data from a study designed to test that speculation.
Interestingly, this cluster of variables only differentiated traumaexposed individuals from HC participants-it did not distinguish those with trauma exposure but no PTSD from those with PTSD. One possible explanation is that although poor sleep quality (measured both subjectively and objectively), elevated evening adrenaline, and poor neutral declarative memory at postsleep awakening are all associated with trauma, sleep fragmentation is a core feature distinguishing trauma-exposed individuals with and without PTSD. An alternative explanation with respect to sexual assault survivors, who comprised the entirety of this sample, is that trauma-exposed individuals without PTSD still bear a high load of trauma symptomology that makes them more similar to their counterparts with PTSD than to HC participants. Support for this speculation emerges from a meta-analysis of neutral declarative memory deficits in PTSD, which found that PTSDdiagnosed participants had poorer memory in comparison with TE participants, except for survivors of sexual assault, where there were no such between-group differences (Johnsen & Asbjornsen, 2008) .
| Strengths and limitations
A strength of the study design is that it controlled for a series of var- One limitation is that participants in the PTSD and TE groups had unmatched depression severity. Previous studies show that depression severity increases proportionally with PTSD symptomology in sexual assault survivors (Au, Dickstein, Comer, Salters-Pedneault, & Litz, 2013) . Given this clinical finding, our sample represents the clinical norm. However, we are unable to fully delineate the specific contributions of PTSD and depression symptomology. Furthermore, although our results suggest features that distinguish PTSD, TE, and HC participants, our study does not provide direct evidence of relationships, causal or otherwise, among these measures. Moreover, the current work characterises these data with the use of a priori defined clinical diagnoses, which may potentially limit prediction/classification accuracies. Finally, this exploratory study applies leave-one-out cross validation in a moderately sized cohort, thus necessitating split sample cross-validation in a larger, nonoverlapping sample of participants.
| Conclusion
Using machine-learning techniques, we were able to differentiate between individuals with (a) trauma exposure versus no trauma expo- 3 RFE is a feature selection method that fits a model and removes the weakest feature (or features) until the specified number of features is reached. Features are ranked by the model's feature importance attributes, and by recursively eliminating a small number of features per loop, RFE attempts to eliminate dependencies and collinearity that may exist in the model.
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